ICE Pharma, a global leader in bile acid–derived APIs, excipients, and finished dosage forms, will showcase its latest innovations at CPhI Worldwide 2025 in Frankfurt, Germany, from October 28–30. Visitors can meet the team at Booth 9.1 A94 to explore sustainable strategies, scientific breakthroughs, and quality-driven solutions.
“At ICE Pharma, quality and environmental responsibility are inseparable,” said Agostino Barazza, Chief Executive Officer. “By mastering bile acids with rigorous controls and sustainable design, we are delivering medicines with impact and integrity.”
“Our sustainability roadmap strengthens operations and inspires confidence across our supply chain, empowering partners to deliver therapies benefiting from bile acid science,” added Roger Viney, Chief Commercial Officer.
Sustainability with Purpose ICE Pharma’s ESG strategy rests on four pillars: Fighting Illness through Product Innovation, Caring for People, Accelerating Sustainable Operations, and Building Strong Relationships. These principles guide decisions across resource management, waste reduction, energy sourcing, and stakeholder engagement.
At CPhI Frankfurt, ICE will present an eco-designed booth built from recyclable materials such as honeycomb cardboard and Linoleum®, following its “Reduce, Reuse, Recycle” philosophy. This third-generation stand, reusing components from past events minimizes environmental impact and demonstrates the company’s commitment to circular design.
Leaders in Bile Acid Science and Quality Manufacturing Known as “The Bile Acids Expert,” ICE Pharma leads in Ursodeoxycholic Acid (UDCA) production and bile acid derivatives. With five R&D centers and supporting dozens of projects in clinical trials, ICE’s products enable therapeutic applications in liver, metabolic, and neurological diseases.
Its robust quality framework ensures traceability, viral inactivation, closed manufacturing systems, and global regulatory compliance, reinforcing ICE’s position as a trusted pharmaceutical partner.
Celebrating 100 Years of ABC Farmaceutici In 2025, ICE Pharma celebrates the centennial of ABC Farmaceutici, founded in 1925 in Turin. ABC’s long-standing expertise complements ICE’s global scale and sustainability-driven approach, particularly in UDCA and finished dosage technologies. Join us at our booth, to celebrate this milestone, on October 28th, at 4:30pm.
Visit ICE Pharma at Booth 9.1 A94 For more information, visit www.icepharma.com
Media Contact: Concetto Andrea Rizza | Marketing & Communication Specialist
+39 0143 48831
+39 342 6126099
c.rizza@iceitaly.com
